S. Cartalat‐Carel

发表

Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas.

F. Ducray, J. Honnorat, D. Frappaz, 2010, Neuro-oncology.

A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy

Johan Pallud, Damien Ricard, Jean-Yves Delattre, 2012, Clinical Cancer Research.

Advances in paraneoplastic neurological syndromes

J. Honnorat, S. Cartalat‐Carel, 2004, Current opinion in oncology.

Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, France.

F. Ducray, J. Honnorat, D. Frappaz, 2014, Revue neurologique.

Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas.

K. Hoang-Xuan, H. Duffau, Y. Marie, 2002, Journal of neurosurgery.

[Supervision of low-grade gliomas with multiparametric MR imaging: research of radiologic indicators of malignancy transformation].

J. Honnorat, D. Frappaz, F. Cotton, 2008, Neuro-Chirurgie.

[Limbic encephalitis. A misdiagnosed syndrome].

F. Ducray, J. Honnorat, S. Cartalat‐Carel, 2008, Psychologie & neuropsychiatrie du vieillissement.

Management of glioblastoma: comparison of clinical practices and cost‐effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital

F. Ducray, J. Honnorat, D. Frappaz, 2014, Journal of clinical pharmacy and therapeutics.

CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.

F. Ducray, J. Honnorat, E. Jouanneau, 2015, Neuro-oncology.

TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study.

R. Guillevin, K. Hoang-Xuan, F. Ducray, 2021, The oncologist.

Gliomatosis Cerebri: A Review of 296 Cases from the ANOCEF Database and the Literature

M. Sanson, S. Taillibert, F. Laigle-Donadey, 2005, Journal of Neuro-Oncology.

[Neurological complications of cancer].

J. Honnorat, S. Cartalat‐Carel, 2003, La Revue du praticien.

Up-front temozolomide in elderly patients with glioblastoma

M. Sanson, J. Honnorat, O. Chinot, 2010, Journal of Neuro-Oncology.

[Management of malignant gliomas diagnosed during pregnancy].

F. Ducray, J. Honnorat, P. Trouillas, 2006, Revue neurologique.

Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies

J. Honnorat, E. Decullier, D. Ricard, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer

I. Rojas-Marcos, J. Delattre, F. Graus, 2003, Medicine.

Characteristics of gliomas in patients with somatic IDH mosaicism

F. Ducray, M. Sanson, C. Dehais, 2016, Acta Neuropathologica Communications.

Interactions between glioma and pregnancy: insight from a 52-case multicenter series.

H. Duffau, L. Capelle, P. Varlet, 2018, Journal of neurosurgery.

Pregnancy increases the growth rates of world health organization grade II gliomas

H. Duffau, E. Mandonnet, L. Capelle, 2009, Annals of neurology.

Pulmonary embolism: An unusual complication of cerebral venous thrombosis

J. Honnorat, P. Trouillas, N. Nighoghossian, 2005, Neurology.

Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.

F. Ducray, J. Honnorat, O. Chinot, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy for glioblastoma in the elderly.

Luc Taillandier, Pierre-Yves Bondiau, Jean-Yves Delattre, 2007, The New England journal of medicine.

Initial chemotherapy in gliomatosis cerebri

K. Hoang-Xuan, H. Duffau, M. Sanson, 2004, Neurology.

Oligodendrogliomas: An update on basic and clinical research

K. Hoang-Xuan, M. Sanson, S. Cartalat‐Carel, 2003, Current neurology and neuroscience reports.

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)

J. Honnorat, D. Frappaz, O. Chinot, 2018, The oncologist.

Peri-ictal pseudoprogression in patients with brain tumor.

M. J. van den Bent, F. Ducray, M. Sanson, 2011, Neuro-oncology.

Current trends in the management of glioblastoma in a French University Hospital and associated direct costs

F. Ducray, J. Honnorat, D. Frappaz, 2016, Journal of clinical pharmacy and therapeutics.

[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study].

B. Chauffert, S. Taillibert, J. Honnorat, 2008, Revue neurologique.

Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis

F. Ducray, J. Honnorat, D. Ricard, 2011, Journal of Neurology.

[Long-term outcome in patients with symptomatic low-grade oligodendrogliomatous tumors treated by cytotoxic agents].

J. Honnorat, P. Trouillas, N. Nighoghossian, 2006, Revue neurologique (Paris).

Characteristics of gliomas in patients with somatic IDH mosaicism

F. Ducray, M. Sanson, J. Honnorat, 2016, Acta neuropathologica communications.

Interactions between glioma and pregnancy: insight from a 52-case multicenter series.

H. Duffau, L. Capelle, P. Varlet, 2018, Journal of neurosurgery.